PULMATRIX, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
PULMATRIX, INC. (PULM) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $81.70 million as of 2025-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-09-17
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $81.70M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $70.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $58.10M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $53.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $81.70M S-4/A · filed 2026-09-17 |
| 2024-12-31 | $70.00M 10-K · filed 2025-03-21 |
| 2023-12-31 | $58.10M 10-K · filed 2024-03-28 |
| 2022-12-31 | $53.20M 10-K · filed 2023-03-30 |
| 2021-12-31 | $50.52M 10-K · filed 2022-03-29 |
| 2020-12-31 | $38.22M 10-K · filed 2021-03-23 |
| 2019-12-31 | $37.60M 10-K · filed 2020-03-26 |
| 2018-12-31 | $149.37M 10-K · filed 2019-02-19 |
| 2017-12-31 | $131.77M 10-K · filed 2018-03-13 |
| 2016-12-31 | $117.15M 10-K · filed 2017-03-10 |
| 2015-12-31 | $102.69M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |